Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $21.39 $36.72
52 weeks $20.67 $41.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Oct 18, 2016 $6.68 $6.72 $6.59 $6.65 364 700
Oct 17, 2016 $6.61 $6.69 $6.43 $6.59 508 800
Oct 14, 2016 $6.97 $6.99 $6.64 $6.64 690 200
Oct 13, 2016 $6.76 $7.09 $6.75 $6.95 667 800
Oct 12, 2016 $6.91 $7.10 $6.81 $6.82 573 800
Oct 11, 2016 $7.16 $7.22 $6.87 $6.95 663 600
Oct 10, 2016 $7.20 $7.28 $7.10 $7.24 624 900
Oct 07, 2016 $7.02 $7.10 $6.80 $7.04 964 100
Oct 06, 2016 $7.45 $7.48 $6.95 $7.03 1 551 200
Oct 05, 2016 $7.34 $7.74 $7.25 $7.52 908 800
Oct 04, 2016 $7.20 $7.40 $7.10 $7.29 765 700
Oct 03, 2016 $7.47 $7.49 $7.12 $7.18 1 001 600
Sep 30, 2016 $7.57 $7.72 $7.25 $7.35 1 751 900
Sep 29, 2016 $8.05 $8.09 $7.20 $7.30 6 591 000
Sep 28, 2016 $7.13 $7.20 $6.83 $7.04 658 900
Sep 27, 2016 $7.07 $7.24 $7.01 $7.13 446 800
Sep 26, 2016 $7.15 $7.22 $7.03 $7.04 432 900
Sep 23, 2016 $7.27 $7.36 $7.16 $7.22 363 500
Sep 22, 2016 $7.29 $7.34 $7.04 $7.27 565 400
Sep 21, 2016 $7.36 $7.48 $6.98 $7.21 799 400
Sep 20, 2016 $7.19 $7.59 $7.16 $7.36 770 600
Sep 19, 2016 $7.10 $7.25 $7.03 $7.08 503 500
Sep 16, 2016 $7.11 $7.27 $7.02 $7.08 1 461 600
Sep 15, 2016 $6.97 $7.24 $6.93 $7.14 566 000
Sep 14, 2016 $6.92 $7.22 $6.89 $7.06 605 100
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT